Remedy Robotics builds the Remedy N1 System, a remotely operable endovascular surgical robotics platform. It lets specialist physicians perform minimally invasive cardiovascular and neurointerventional procedures from any location by combining proprietary robotic hardware with AI-powered software. A portable console lets remote clinicians control multiple tools (guidewires, catheters, stents) inside catheterization labs, while AI fuses imaging data from CT, MRI, and fluoroscopy for real-time navigation. The company differentiates itself by enabling true teleoperation to overcome geographic care gaps, demonstrated by the world’s first fully remote neurointerventional procedures in humans across two hospitals. Its goal is to expand access to gold-standard endovascular treatments for millions of patients who currently lack timely specialist care, by scaling deployment in hospitals and enhancing its AI capabilities.
Company Size
11-50
Company Stage
Series A
Total Funding
$35M
Headquarters
San Francisco, California
Founded
2020
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?